Eisai
4523.T
#2188
Rank
HK$65.67 B
Marketcap
HK$232.79
Share price
-0.15%
Change (1 day)
2.30%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): HK$6.78

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.74. an increase over its 2024 EPS that were of HK$7.60.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$8.5011.85%
2024HK$7.60-32.63%
2023HK$11.285.52%
2022HK$10.69-74.01%
2021HK$41.12-66.58%
2020HK$123.0398.24%
2019HK$62.0617.01%
2018HK$53.0437.78%
2017HK$38.49-27.62%
2016HK$53.1935.33%
2015HK$39.30-2.82%
2014HK$40.44-27.66%
2013HK$55.91-27.49%
2012HK$77.11-12.67%
2011HK$88.3088.08%
2010HK$46.95-11.06%
2009HK$52.79-390.15%
2008-HK$18.19-127.78%
2007HK$65.5011.78%
2006HK$58.604.38%
2005HK$56.147.4%
2004HK$52.2843.03%
2003HK$36.5525.09%
2002HK$29.2252.67%
2001HK$19.1469.76%
2000HK$11.27